- Report
- September 2023
- 381 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
From €3598EUR$3,750USD£3,111GBP
- Report
- April 2024
- 175 Pages
From €4797EUR$5,000USD£4,148GBP
- Report
- August 2018
- 125 Pages
Europe
From €4749EUR$4,950USD£4,107GBP
- Report
- April 2023
- 110 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- January 2020
- 247 Pages
Global
From €3454EUR$3,600USD£2,987GBP
- Report
- December 2023
- 150 Pages
Global
From €2686EUR$2,799USD£2,322GBP
- Book
- October 2022
North America
The Oncology Imaging market is a subset of the Medical Imaging market, which focuses on the diagnosis and treatment of cancer. Oncology Imaging technologies include X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and nuclear medicine. These technologies are used to detect, diagnose, and monitor cancer, as well as to assess the effectiveness of treatments. Oncology Imaging is also used to detect metastases and to plan radiation therapy.
Oncology Imaging is an important tool in the fight against cancer, as it allows for early detection and diagnosis, which can lead to better outcomes for patients. It also helps to reduce the cost of cancer care by providing more accurate diagnoses and treatments.
Companies in the Oncology Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, Toshiba Medical Systems, Shimadzu Corporation, and Hologic. Show Less Read more